Literature DB >> 17165091

Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.

Peter Weyrich1, Norbert Stefan, Hans-Ulrich Häring, Markku Laakso, Andreas Fritsche.   

Abstract

Lifestyle intervention programs including increased physical activity and healthy nutrition have been proven to delay the onset of type 2 diabetes. This is achieved mainly by reducing body weight and improving insulin sensitivity. However, response to lifestyle or dietary interventions does differ between individuals, and the genetic or environmental factors that may account for these differences are not yet precisely characterized. Identification of these factors would be desirable in order to provide an individually tailored preventive strategy for patients at risk of developing diabetes. This review summarizes the so far known genetic variations, which determine responders and nonresponders to a lifestyle intervention. In addition, general methodological approaches to study gene-lifestyle interactions are described.

Entities:  

Mesh：

Year:  2006        PMID： 17165091     DOI： 10.1007/s00109-006-0134-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


  58 in total

1.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

2.  Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes.

Authors:  Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Roland Perfekt; Kaj Lahti; Michael Nissén; Bo Isomaa; Björn Forsen; Nils Homström; Carola Saloranta; Marja-Riitta Taskinen; Leif Groop; Tiinamaija Tuomi
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 3.  New imaging techniques of fat, muscle and liver within the context of determining insulin sensitivity.

Authors:  Norbert Stefan; Jürgen Machann; Fritz Schick; Claus D Claussen; Claus Thamer; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Horm Res       Date:  2006-01-20

4.  Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study.

Authors:  David E Laaksonen; Jaana Lindström; Timo A Lakka; Johan G Eriksson; Leo Niskanen; Katja Wikström; Sirkka Aunola; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Timo T Valle; Pirjo Ilanne-Parikka; Anne Louheranta; Helena Hämäläinen; Merja Rastas; Virpi Salminen; Zygimantas Cepaitis; Martti Hakumäki; Hannu Kaikkonen; Pirjo Härkönen; Jouko Sundvall; Jaakko Tuomilehto; Matti Uusitupa
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

5.  Evidence for gene-nutrient interaction at the PPARgamma locus.

Authors:  J Luan; P O Browne; A H Harding; D J Halsall; S O'Rahilly; V K Chatterjee; N J Wareham
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

6.  Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.

Authors:  Laura J Scott; Lori L Bonnycastle; Cristen J Willer; Andrew G Sprau; Anne U Jackson; Narisu Narisu; William L Duren; Peter S Chines; Heather M Stringham; Michael R Erdos; Timo T Valle; Jaakko Tuomilehto; Richard N Bergman; Karen L Mohlke; Francis S Collins; Michael Boehnke
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

7.  Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.

Authors:  Coleen M Damcott; Toni I Pollin; Laurie J Reinhart; Sandra H Ott; Haiqing Shen; Kristi D Silver; Braxton D Mitchell; Alan R Shuldiner
Journal:  Diabetes       Date:  2006-09       Impact factor: 9.461

8.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Authors:  Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

Review 9.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

10.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112
View more
  11 in total

1.  The ENPP1 K121Q polymorphism determines individual susceptibility to the insulin-sensitising effect of lifestyle intervention.

Authors:  K Müssig; M Heni; C Thamer; K Kantartzis; F Machicao; N Stefan; A Fritsche; H-U Häring; H Staiger
Journal:  Diabetologia       Date:  2009-11-29       Impact factor: 10.122

2.  Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion.

Authors:  Martin Heni; Caroline Ketterer; Claus Thamer; Silke A Herzberg-Schäfer; Martina Guthoff; Norbert Stefan; Fausto Machicao; Harald Staiger; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes       Date:  2010-08-29       Impact factor: 9.461

Review 3.  [Gene-environment interactions in the pathogenesis and prevention of type 2 diabetes mellitus].

Authors:  A Fritsche; C Thamer; N Stefan; H U Häring
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

4.  Impact of positive family history and genetic risk variants on the incidence of diabetes: the Finnish Diabetes Prevention Study.

Authors:  Matti I Uusitupa; Alena Stancáková; Markku Peltonen; Johan G Eriksson; Jaana Lindström; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Markku Laakso
Journal:  Diabetes Care       Date:  2010-10-27       Impact factor: 19.112

5.  Impact of ENPP1 K121Q on change of insulin resistance after web-based intervention in Korean men with diabetes and impaired fasting glucose.

Authors:  Ji Yeon Kang; Sook Hee Sung; Yeon Ju Lee; Tae In Choi; Seung Jin Choi
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153

Review 6.  Sources of Inter-individual Variability in the Therapeutic Response of Blood Glucose Control to Exercise in Type 2 Diabetes: Going Beyond Exercise Dose.

Authors:  Thomas P J Solomon
Journal:  Front Physiol       Date:  2018-07-13       Impact factor: 4.566

Review 7.  Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?

Authors:  Paul W Franks; Alaitz Poveda
Journal:  Diabetologia       Date:  2017-01-25       Impact factor: 10.122

8.  Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans.

Authors:  Harald Staiger; Carina Haas; Jürgen Machann; Roman Werner; Melanie Weisser; Fritz Schick; Fausto Machicao; Norbert Stefan; Andreas Fritsche; Hans-Ulrich Häring
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

Review 9.  Exercise and diabetes: relevance and causes for response variability.

Authors:  Anja Böhm; Cora Weigert; Harald Staiger; Hans-Ulrich Häring
Journal:  Endocrine       Date:  2015-12-07       Impact factor: 3.633

10.  Effectiveness of a Yoga-Based Lifestyle Protocol (YLP) in Preventing Diabetes in a High-Risk Indian Cohort: A Multicenter Cluster-Randomized Controlled Trial (NMB-Trial).

Authors:  Nagarathna Raghuram; Venkat Ram; Vijaya Majumdar; Rajesh Sk; Amit Singh; Suchitra Patil; Akshay Anand; Ilavarasu Judu; Srikanta Bhaskara; Jagannadha Rao Basa; Hongasandra Ramarao Nagendra
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-11       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.